What is Sky Labs?
Founded in 2015 and headquartered in South Korea, Sky Labs is at the forefront of preventative healthcare, leveraging signal big data to develop advanced health monitoring solutions. The company's flagship product is CART, a ring-type medical device designed for the simple detection of Atrial Fibrillation (AF). Sky Labs' proprietary algorithm boasts an impressive 98% accuracy in AF detection, positioning the company as a key player in the wearable health technology market. The recent enterprise-level funding underscores the market's confidence in Sky Labs' technology and its potential to revolutionize early disease detection.
How much funding has Sky Labs raised?
Sky Labs has raised a total of $34.3M across 2 funding rounds:
Series A
$4.3M
Series B
$30M
Series A (2019): $4.3M with participation from TBT
Series B (2021): $30M led by KB Investment, LB Investment, Atinum Investment, Moru Asset Management, Korea Investment Partners, and Soo Investment Capital
Key Investors in Sky Labs
TBT
TBT is an investment firm that likely focuses on strategic partnerships and capital allocation within the technology and healthcare sectors, given its domain.
KB Investment
KB Investment is a venture capital firm established in 1990, specializing in investments in innovative technology, service, and entrepreneurship, with a strong presence in Seoul, South Korea.
LB Investment
LB Investment focuses on transformative technologies that enhance human life, supporting visionary entrepreneurs in developing groundbreaking innovations across sectors like deep-tech and healthcare.
What's next for Sky Labs?
With its latest funding round, Sky Labs is poised for significant expansion and further technological development. The company's focus on a vital, data-driven approach to preventative healthcare, particularly in detecting conditions like Atrial Fibrillation, aligns with the growing global demand for accessible and accurate health monitoring tools. Future strategic initiatives will likely involve scaling production of the CART device, enhancing its algorithmic capabilities through continued R&D, and expanding its market reach both domestically and internationally. This investment will be crucial in solidifying Sky Labs' position as a leader in the digital health and medtech sectors.
See full Sky Labs company page
